Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Publication stageIn Press Journal Pre-Proof
• Following the COVID-19 induced transition to virtual healthcare, innovative approaches to the medical management of diabetes in pregnancy are needed, such as mobile health (mHealth) technology that facilitates patient-provider communication.
• Women with diabetes appear to benefit from some aspects of mHealth during pregnancy.
• The co-design of future technologies with end-users may help address the patient-reported limitations of mHealth technologies.
Author Disclosures: Conflicts of interest, none
Funding: KS and HT are supported through graduate scholarships. DS acknowledges the Heather M. Arthur Population Health Research Institute/Hamilton Health Sciences Chair in Inter-Professional Health Research. KN acknowledges Heart and Stroke and the Canadian Institutes of Health Research for the Women’s Heart and Brain Health Midcareer Research Chair.